Ra Medical Systems Announces Allowance Of New Closure Device Patent; First Patent Out Of Six Applications On File For LockeT Product
Portfolio Pulse from Happy Mohamed
Ra Medical Systems, Inc. (NYSE:RMED) has received notification of allowance for the first patent for its LockeT product, a vessel closing device. This is the first of six patent applications on file in the US and several foreign countries. The company expects the product to be successful in the market for assisting in the closure of percutaneous wound sites.
August 14, 2023 | 12:47 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Ra Medical Systems has received the first patent for its LockeT product. This could potentially increase the company's market share in the medical device sector.
The allowance of the first patent for the LockeT product could potentially increase Ra Medical Systems' competitiveness in the medical device market. This could lead to an increase in the company's revenues and potentially its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100